Annual Meeting Scientific Plenaries

0414-annual-meeting-on-Womens-cancer

Annual Meeting | Registration | Continuing Education | Housing and Travel Schedule

2018 SGO Annual Meeting Scientific Plenaries

The latest peer-reviewed science, research, and practice for the treatment of gynecologic cancers will be presented, discussed, debated, and analyzed in the Scientific Plenaries.

Download Abstract Titles

 

Scientific Plenary I: Opening Scientific Plenary
Scientific Plenary II: Contemporary Challenges
Scientific Plenary III: PARP-pourri
Scientific Plenary IV: Abstracts Current Trials, Emerging Targets
Scientific Plenary V: Scientific Plenary V: The Farr Nezhat Surgical Innovation Session: Surgical Decision Making in Advanced Ovarian Cancer
Scientific Plenary VI: Immuno-Oncology
Scientific Plenary VII: Improving Patient Experience and Outcomes
Scientific Plenary VIII: Scientific Plenary VIII: Last But Not Least…

Scientific Plenary Session I

Saturday, March 24, 2018
8:20 a.m. – 9:50 a.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Kenneth H Kim, FACOG, FACS, MD, University of Alabama at Birmingham, Birmingham, AL, USA
Pamela T. Soliman, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Barriers to receiving health care, social discrimination, and cultural factors all contribute to racial and ethnic disparities in the prevention, detection, and high-quality treatment of gynecologic cancers. Learn about research identifying the causes of and discuss strategies to reduce racial disparities through policy and practice.

Scientific Plenary Session II: Contemporary Challenges 

Saturday, March 24, 2018
10:20 a.m. – 12:00 p.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Shitanshu Uppal, MD, MBBS, University of Michigan Health Systems, Ann Arbor, MI, USA
Jason A. Lachance, MD, Maine Medical Partners, Scarborough, ME, USA

Scientific Plenary Session III: PARP-pourri

Sunday, March 25, 2018
8:00 a.m. – 9:00 a.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Lori Cory, MD, University of Pennsylvania, Philadelphia, PA, USA
Lejla Delic, MD, California Pacific & Palo Alto Medical Foundation/Sutter Research Institute, San Francisco, CA, USA

PARP inhibitors continue to change the landscape of ovarian cancer treatment. Get an update on the science and research into this promising treatment in this specially curated session.

Scientific Plenary Session IV: Abstracts Current Trials, Emerging Targets

Sunday, March 25, 2018
1:45 p.m. – 2:45 p.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
David cantu de León, MD, Instituto Nacional de Cancerlogía of Mexico, Tlalpan, Mexico
Victoria L. Bae-Jump, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Discussants:
Michael Bookman, MD, Kaiser Permanente, San Francisco, PA
Oliver Dorigo, MD, PhD, Stanford University, Palo Alto, CA

Scientific Plenary V: The Farr Nezhat Surgical Innovation Session: Surgical Decision Making in Advanced Ovarian Cancer

Monday, March 26, 2018
11:15 a.m. – 12:30 p.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Vanna Zanagnolo, MD, European Institute of Oncology, Milan, Italy
Ahmed N. AL-Niaimi, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Speakers:
Bill Cliby, MD, Mayo Clinic, Rochester, MN
Robert Bristow, MD, University of California at Irvine, Orange, CA

This year’s focus for the Farr Nezhat Surgical Innovations Session: Surgical Decision Making in Advanced Ovarian Cancer is the assessment and initial decision making for the optimal use of surgery in the primary management of advanced stage ovarian cancer. We will hear the perspectives of recognized leaders on risk-based triage strategies, use of laparoscopy for initial assessment and planning, and international variations in approach. This is sure to be a valuable session to better understand the emerging research on initial surgical decision making.

Farr Nezhat, MD, FACOG, FACS, in collaboration with his brothers Camran Nezhat, MD, FACOG, FACS, who developed the technique of Video Assisted Endoscopy that revolutionized modern day surgery, and Ceana Nezhat, MD, FACOG, FACS, performed some of the most advanced endoscopic procedures for the first time, including a radical hysterectomy, paraortic and pelvic node dissection, bowel, bladder, ureter, diaphragm resection sacrocolpopexy, vesico-vaginal fistula and major vascular injury repairs and laparoscopy during advanced stages of pregnancy. By doing so, they opened the path for endoscopic surgeons all over the world, to the benefit of patients globally.

Scientific Plenary VI: Immuno-Oncology

Tuesday, March 27, 2018
7:30 a.m. – 8:30 a.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Monica B. Jones, MD
Amir Anthony Jazaeri, MD, University of Virginia, Charlottesville, VA, USA

Although immunotherapy has demonstrated effectiveness in many cancers, its use in gynecologic cancers remains an active area of ongoing clinical research. Learn the latest on this still-developing treatment and what it could mean for the future of gynecologic oncology.

Scientific Plenary VII: Improving Patient Experience and Outcomes

Tuesday, March 27, 2018
8:40 a.m. – 10:00 a.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Gregg Nelson, MD, Tom Baker Cancer Centre, Calgary, Canada
Kian Behbakht, MD, University of Colorado Denver, Aurora, CO, USA

Scientific Plenary VIII: Last But Not Least…

Monday, March 26, 2018
10:00 a.m. – 11:00 a.m.
Hyatt New Orleans, Celestin Ballroom

Moderators:
Elizabeth Jewell, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Renata Urban, MD, University of Washington Medical Center, Seattle, WA

Register for the Meeting